Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - olanzapine -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - olanzapine -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - olanzapine -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - olanzapine -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - olanzapine, quantity: 15 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; lactose monohydrate; magnesium stearate; purified talc; hyprolose; titanium dioxide; iron oxide yellow; xanthan gum; polyvinyl alcohol; iron oxide black; lecithin; indigo carmine aluminium lake - for the treatment of schizophrenia and related psychoses. ,alone or in combination with lithium or valproate, it is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - olanzapine -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - olanzapine -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - olanzapine -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - olanzapine -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - olanzapine, quantity: 20 mg - tablet, film coated - excipient ingredients: crospovidone; magnesium stearate; lactose monohydrate; purified talc; microcrystalline cellulose; hyprolose; titanium dioxide; xanthan gum; polyvinyl alcohol; lecithin; iron oxide yellow; iron oxide red; iron oxide black - for the treatment of schizophrenia and related psychoses. ,alone or in combination with lithium or valproate, it is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.